BRADLEY J SCOTT

Allopathic & Osteopathic Physicians|Family Medicine GRANGER, IN NPI 1720078835

General Payments — all program years on this page

$450.66

  • Category: General Payments
  • Program years: PY2019–2024
  • Record count: 24
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $424.87 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $424.8722

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2019 $14.231
2021 $11.561
2024 $424.8722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1097519214 Novo Nordisk Inc $22.10 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097832530 Novo Nordisk Inc $24.70 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104278753 AstraZeneca Pharmaceuticals LP $14.21 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105636738 AstraZeneca Pharmaceuticals LP $16.49 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106047688 ABBVIE INC. $26.86 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106047690 ABBVIE INC. $18.98 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106047692 ABBVIE INC. $23.70 10/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106047694 ABBVIE INC. $22.87 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117378016 Amgen Inc. $13.53 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118126771 Boehringer Ingelheim Pharmaceuticals, Inc. $15.00 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118126773 Boehringer Ingelheim Pharmaceuticals, Inc. $18.16 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125216796 Abbott Laboratories $14.64 12/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130881536 PFIZER INC. $14.93 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136017767 Lilly USA, LLC $14.89 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136067654 Lilly USA, LLC $18.18 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136067656 Lilly USA, LLC $15.15 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136073473 Lilly USA, LLC $16.01 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136074733 Lilly USA, LLC $14.93 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145966854 Lundbeck LLC $18.57 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145966856 Lundbeck LLC $18.19 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148108120 Inspire Medical Systems, Inc. $46.65 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153287239 Dexcom, Inc. $16.13 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.